In agreement with this, Xiong and colleagues recently reported that USP8 inhibition triggers the innate immune response by activating the NF-κB pathway in CT26 cells (murine colorectal carcinoma; Xiong et al., 2022). Here, NFKB1 is linked to colorectal carcinoma.